Juvenescence Uk Ltd
JU
About
Juvenescence is a biotechnology company dedicated to developing and commercializing therapies that target the fundamental biological processes of aging. Their mission is to extend human healthspan and improve quality of life by addressing age-related diseases.
Key facts
At-a-glance profile data
- Website
- juvenescence.io
- Headquarters
- London, United Kingdom
- Founded
- 2017
- Total funding
- $150M (Series B)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 1 Jul 2018 | Series B | $130M | Adam Smith |
| 1 Jan 2017 | Seed | $20M | - |
Add first review
Frequently asked
How much funding has Juvenescence Uk Ltd raised?
Juvenescence Uk Ltd has raised a total of $150M in funding. The most recent round on record is Series B.
What is Juvenescence Uk Ltd's current status?
Juvenescence Uk Ltd's current operating status is: Inactive.